Salient Surgical Technologies New AQUAMANTYS3 System with Advanced Cutting and Hemostatic Sealing Device Proves Successful in First Surgical Case

Published: Oct 21, 2010

PORTSMOUTH, N.H.--(BUSINESS WIRE)--Salient Surgical announced today that the company has completed the first human cases in Europe using its new AQUAMANTYS®3 System. The new system includes a handpiece that combines for the first time Salient’s patented TRANSCOLLATION® technology for hemostatic sealing of soft tissue and bones with cutting capabilities.

Back to news